Enrique Herrera‐Acosta

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

E. Daudén, G. Carretero, R. Rivera et al. · Journal of the American Academy of Dermatology · 2020 · 54 citations

Adverse Events, Spanish Registry, Medicine +6

Photodynamic therapy in the treatment of extensive Bowen's disease

Norberto López, Teresa Meyer-González, Enrique Herrera‐Acosta et al. · Journal of Dermatological Treatment · 2011 · 43 citations

Prediction of Sentinel Lymph Node Positivity by Growth Rate of Cutaneous Melanoma

A. Tejera‐Vaquerizo, Eduardo Nagore, Enrique Herrera‐Acosta et al. · Archives of Dermatology · 2012 · 32 citations

Chronology of Metastasis in Cutaneous Melanoma: Growth Rate Model

A. Tejera‐Vaquerizo, Eduardo Nagore, Juan J. Meléndez et al. · Journal of Investigative Dermatology · 2012 · 30 citations · Full text

Medicine, Cutaneous Biology, Melanoma +5

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

C. Hernández-Fernández, G. Carretero, R. Rivera et al. · Acta Dermato Venereologica · 2020 · 30 citations · Full text

Sexual Health, Systemic Psoriasis Therapy, Medicine +15